COVALONGUARD SPRAY

Approval Id: adb2fb6149e0f5ab
Drug Approval Canada Name: COVALONGUARD SPRAY
Product Name: COVALONGUARD SPRAY
Status: Cancelled Post Market
Status Date: 2021-08-31
Original Market Date: 2020-06-26
Din: 02499754
Drug Class: Human
Dosage Form: Spray
Route Of Administration: Topical
Schedule: OTC
Ahfs: 84:04.92
Atc Original: D08AJ01 BENZALKONIUM
Atc Name: d 08 aj 01
Aig Number: 0104993016
Company Name: Covalon Technologies Inc
Company Address: UNIT 5, 1660 Tech Ave, Mississauga, Ontario, Canada, L4W 5S7
Company Detail Path: /organization/covalon-technologies-inc

BENZALKONIUM CHLORIDE

0.13 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

adb2fb6149e0f5ab

Type

Standard